by Stephanie DeMarco, PhD – Drug Discovery News

Scientists and engineers teamed up to use robots to streamline cell therapy manufacturing, aiming to give more patients access to these lifesaving therapies.

Now, a team of engineers at the biotechnology company Multiply Labs may have found a way to both decrease risks of contamination and batch effects while also removing the need for an expensive labor force. Their solution? Robots.

Read the article – Click here